`Arava' [leflunomide] labelling in the US now includes more explicit liver function monitoring directions

Source: Reactions Weekly, Volume 1, Number 960, 2003 , pp. 3-3(1)

Publisher: Adis International

Keywords: Labelling; Leflunomide, adverse reactions; Liver-disorders, drug-induced

Document Type: Short communication

Publication date: 2003-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers